Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Giuseppe Fasolino actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Onderzoeksoutput
-
A phase 2 clinical trial of regorafenib in patients with advanced pretreated melanoma (RegoMel)
Dirven, I., Vounckx, M., Kessels, J. I. E., Vanlaer, N., von Kemp, B., Fasolino, G. & Neyns, B., 1 jun 2024, In: Journal of Clinical Oncology. 42, 16, 9518.Onderzoeksoutput: Meeting abstract (Journal)
Open Access -
Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAFV600/NRASQ61 Wild-Type Melanoma (TraMel-WT)
Awada, G., Dirven, I., Schwarze, J. K., Tijtgat, J., Fasolino, G., Kockx, M. & Neyns, B., 15 feb 2024, In: JCO precision oncology. 8, blz. 1-10 10 blz., PO.23.00493.Onderzoeksoutput: Article › peer review
Open AccessBestand3 Citaten (Scopus)25 Downloads (Pure) -
Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study
Fasolino, G., Awada, G., Moschetta, L., Koulalis, J. S., Neyns, B., Verhelst, B., Van Elderen, P., Nelis, P., de Lichtbuer, P. C., Cools, W. & Ten Tusscher, M., 3 feb 2023, In: Journal of clinical medicine. 12, 3, 10 blz., 1214.Onderzoeksoutput: Article › peer review
Open AccessBestand2 Citaten (Scopus)14 Downloads (Pure) -
Retinal alterations associated with targeted cancer therapy
Fasolino, G., 2023, 130 blz.Onderzoeksoutput: PhD Thesis
Open AccessBestand193 Downloads (Pure) -
A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Kruse, V. & Neyns, B., 1 jun 2022, In: Melanoma Research. 32, 3, blz. 183-191 9 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand12 Citaten (Scopus)64 Downloads (Pure)
Activiteiten
-
Greek Vitreo-Retinal Society
Giuseppe Fasolino (Speaker)
1 feb 2024Activiteit: Talk or presentation at a conference
-
JCO precision oncology (Tijdschrift)
Giuseppe Fasolino (Editor)
14 feb 2024Activiteit: Publication peer-review
-
Bilateral Macular Edema of unknown Origin during Pregnancy
Shervine Ameli (Speaker) & Giuseppe Fasolino (Speaker)
28 nov 2024Activiteit: Talk or presentation at a conference
-
Diabetes Liga (Externe Organisatie)
Giuseppe Fasolino (Chair)
19 apr 2024 → 19 apr 2027Activiteit: Membership of external research organisation
-
Scriptie
-
Retinal alterations associated with targeted cancer therapy
Auteur: De Asmundis, C., Fasolino, G., Neyns, B. & Raus, P., 4 dec 2023Scriptie/Masterproef: Master-after-master